Suppr超能文献

肾小球压力与肾小管氧供:肾脏保护的关键双重靶点

Glomerular pressure and tubular oxygen supply: a critical dual target for renal protection.

作者信息

Masuda Takahiro, Nagata Daisuke

机构信息

Division of Nephrology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.

出版信息

Hypertens Res. 2024 Dec;47(12):3330-3337. doi: 10.1038/s41440-024-01944-9. Epub 2024 Oct 14.

Abstract

The primary treatment goal of chronic kidney disease (CKD) is preserving renal function and preventing its progression to end-stage renal disease. Glomerular hypertension and tubular hypoxia are critical risk factors in CKD progression. However, the renal hemodynamics make it difficult to avoid both factors due to the existence of peritubular capillaries that supply oxygen to the renal tubules downstream from the glomerulus through the efferent arteriole. In the treatment strategies for balancing glomerular pressure and tubular oxygen supply, afferent and efferent arterioles of the glomerulus determine glomerular filtration rate and blood flow to the peritubular capillaries. Therefore, sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors as well as classical renin-angiotensin system inhibitors, which can change the diameter of afferent and/or efferent arterioles, are promising options for balancing this dual target and achieving renal protection. This review focuses on the clinical importance of glomerular pressure and tubular oxygen supply and proposes an effective treatment modality for this dual target.

摘要

慢性肾脏病(CKD)的主要治疗目标是保护肾功能并防止其进展为终末期肾病。肾小球高血压和肾小管缺氧是CKD进展的关键危险因素。然而,由于存在通过出球小动脉向肾小球下游的肾小管供应氧气的周细胞毛细血管,肾脏血流动力学使得难以同时避免这两个因素。在平衡肾小球压力和肾小管氧气供应的治疗策略中,肾小球的入球小动脉和出球小动脉决定肾小球滤过率和流向周细胞毛细血管的血流量。因此,钠-葡萄糖协同转运蛋白2抑制剂、血管紧张素受体脑啡肽酶抑制剂以及经典的肾素-血管紧张素系统抑制剂,这些能够改变入球和/或出球小动脉直径的药物,是平衡这一双重目标并实现肾脏保护的有前景的选择。本综述重点关注肾小球压力和肾小管氧气供应的临床重要性,并提出针对这一双重目标的有效治疗方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验